{
  "docId": "019f6b8f-36f5-748e-b966-b9484f2486e9",
  "docSlug": "jarvis-mckinsey-forecasting-hca-healthcare-ebitda-performance",
  "documentTitle": "McKinsey Forecasting HCA Healthcare EBITDA performance",
  "authorId": "mckinsey-forecasting-hca-healthcare-ebitda-performance",
  "authorName": null,
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": null,
  "aspectRatio": null,
  "pageNumber": 15,
  "pageCount": 18,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "cost_structure",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "Slide 5 of a deck, page 14.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019f6b8f-36f5-748e-b966-b9484f2486e9/15",
  "deckHref": "/decks/019f6b8f-36f5-748e-b966-b9484f2486e9",
  "deckJsonHref": "/decks/019f6b8f-36f5-748e-b966-b9484f2486e9.json",
  "deckAnchorHref": "/decks/019f6b8f-36f5-748e-b966-b9484f2486e9#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.225,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Breakdown of 2005 cost Percent",
      "attrs": null,
      "subkind": "pie",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed75a406-5559-40d7-bf78-7999eb2ccee9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.7,
        "x": 0.24,
        "y": 0.5
      },
      "kind": "list",
      "text": "Supply cost growth will stay in current range due to: No major new medical device/drug technology introductions. Continued impact from ongoing standardization initiatives across categories.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "966937df-aa6d-46fb-ac1c-59b1abef4120",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.51,
        "y": 0.15
      },
      "kind": "list",
      "text": "Pharmaceuticals and medical devices have been primary drivers of supply cost growth in recent years. Forecast based on growth rate projections for each category. With reductions for cost management programs and rebates.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "97a80ad3-f436-423c-937b-51e6c186b4e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.7,
        "x": 0.24,
        "y": 0.7
      },
      "kind": "list",
      "text": "New technologies (historical source of volatility but none anticipated in next 3 years). Uncertainty around future device / pharmaceutical pricing. Challenge in continually identifying next $40M in savings programs.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9bd714f9-e1bf-4c78-b371-bd8dc59edc74",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.02,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Team analysis",
      "attrs": null,
      "subkind": "source-note",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d47f34b3-267a-4afa-93a9-5d4ff34a84a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.95,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "5 SUPPLY COST GROWTH IS EXPECTED TO RISE SOMEWHAT TO 7.8%, BUT STAY BELOW 02-04 LEVEL",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8687cb07-c106-4bc8-b53a-ff5be7fa3a9e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 18,
      "from": 15,
      "beatId": "b5f199aa-32ea-4011-aede-7e813cbec50f",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The scenario analysis and appendix disclosures provide insights into potential future outcomes and implications",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 18,
      "from": 15,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "f53edb29-a8ab-4587-8916-51046384bcbf",
      "evidence": "The scenario analysis suggests potential EBITDA ranges and implications for future performance",
      "position": 1,
      "objective": "Highlight the potential consequences of not adopting McKinsey's projections",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}